Jefferies Group LLC currently has a $13.00 price target on the stock, up from their previous price target of $11.00. Several other analysts have also issued reports on PGNX.
Category: Healthcare Industry
Beyond Lyme: New Tick-Borne Diseases On The Rise In U.S.
At the time, Lane didn’t think much about it. He grew up on Cape Cod. Ticks are everywhere there in the summer.
Deborah Ann Rogers v. Mentor Corporation Mentor LLC Victoria Kearse
No. 16-10119, No. 16-10120, No. 16-10122, No. 16-10124, No. 16-10351, No. 16-10354, No.
Pfizer And Merck Go For An Even Longer Throw Of The Javelin
Pfizer and Merck KGaA’s tweaks to the Javelin Lung 100 study of their PD-L1 antibody avelumab, which will delay its readout by almost two years, look like a painful but necessary adjustment to commercial realities in this competitive cancer indication. The changes will more than double the size of the study, in first-line non-small cell lung cancer, and push data out to mid-2019.
Caring for a childa s animal bite or scratch
It’s important to make sure children know how to be safe around animals, including the family pet. Experts say most bites come from animals a child knows.
Losses For Drugmakers, Hospitals Pull Stocks Lower – SIn Center Stage
U.S. stocks declined for the third time in four days on Tuesday as health care companies took center stage.
Cardiac Rehabilitation Market: Emergence of Advanced Technologies and Global Industry Analysis 2024
… helped in boosting the demand for casting and splinting supplies. “However, unfavorable reimbursement policies and health insurance covers have been acting against the market’s growth prospects,” said a lead TMR analyst. “The lack of government as …
Deutsche Bank Reaffirms GBX 300.00 TP On Convatec Group Plc…
Deutsche Bank Reaffirms GBX 300.00 TP On Convatec Group Plc , Reaffirms “Buy” Rating; Agco SI Decreased By 11.43% Agco Corporation had a decrease of 11.43% in short interest. AGCO’s SI was 6.61M shares in March as released by FINRA.
Ablynx’s Partner, Merck KGaA, Has Presented New Data from a Phase Ib…
GHENT, Belgium, 6 March 2017 – Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that its partner, Merck KGaA , has presented new data from a Phase Ib study demonstrating strong efficacy with the bi-specific anti-IL-17A/F Nanobody® in patients with moderate-to-severe chronic plaque psoriasis. The results were presented at the 75th Annual Meeting of the American Academy of Dermatology Conference, taking place from 3-7 March 2017, in Orlando, Florida.
Tanning can contribute to skin ageing
… can negatively impact the skin, as can pollution, so protecting your skin from the environment can benefit both your health and appearance, Kourosh said in a statement released by the American Academy of Dermatology. Since both types of UV rays — …
Diabetes prevention help offered
Alamance Regional Medical Center has partnered with the county health department to teach a class directed toward diabetes prevention in nine area counties. In North Carolina, it’s about 1,075,855, roughly 13.1 percent of the adult population.
Wedbush Weighs in on DexCom, Inc.’s Q1 2017 Earnings
Investment analysts at Wedbush issued their Q1 2017 earnings estimates for shares of DexCom in a research note issued to investors on Wednesday. Wedbush analyst Levy.
More Teens Turning Their Backs on Tanning Beds
… indoor tanning appears to give them a false sense of security when they step outdoors into real sunlight, said Guy, a health economist with the CDC’s division of cancer prevention and control. “We also found that among the 1.2 million high school …
Celgene to Present New Data from Clinical Trials on Oral OTEZLA…
Celgene Corporation today announced that findings from ongoing clinical trials of OTEZLA , the Company’s oral, selective inhibitor of phosphodiesterase 4 , conducted in patients with moderate or moderate to severe plaque psoriasis, and in adult patients with active psoriatic arthritis, will be presented at the 75th Annual Meeting of the American Academy of Dermatology in Orlando, Florida. Ten abstracts will be presented at the meeting.
Children’s Hospital at St Francis receives check 28 mins ago
Dozens stood outside on the Children’s playground at St. Francis Hospital as Gold 4 Kids of Tulsa presented a check of $70,00 to the hospital’s staff. Gold 4 Kids, a cancer fundraising organization, focuses on raising money for research, clinical trails, and special projects in order to support the clinical pediatric oncology department at St. Francis hospital.
Instinet Initiates Coverage on Biogen Inc
The firm set a “buy” rating and a $345.00 price target on the stock. Biogen traded up 0.84% during trading on Thursday, reaching $295.71.
FDA OKs Merck’s allergen extract to treat house dust mite-induced allergic rhinitis
The FDA approves Merck’s Odactra, the first allergen extract that is administered sublingually to treat house dust mite-induced nasal inflammation , with or without eye inflammation in people between the ages of 18 and 65. Odactra, a once-daily tablet that rapidly dissolves under the tongue, exposes patients to house dust mite allergens with the aim of gradually training the immune system to reduce the frequency and severity of nasal and eye allergy symptoms. It is taken year-round.
Surrey woman part of $6.2M drug award
Faith Gibson holds her two-year-old daughter Meah Bartram in 2008. The little girl was born with a hole in her heart, a condition Gibson believes was caused by the doctor-prescribed anti-anxiety medication she was taking while pregnant.
Perrigo Company plc (PRGO) Rating Reiterated by Canaccord Genuity
… over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug …
After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B
Perrigo also said it will review its API business, which provides differentiated active pharmaceutical ingredients and finished dosage forms for the branded and generic industries. Perrigo , the Dublin-based manufacturer of over-the-counter drugs, announced Monday it will divest its royalty stream for multiple sclerosis drug Tysabri to an affiliate of Royalty Pharma for up to $2.85 billion.
3 Top Healthcare Stocks to Buy Now
… lthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights
La Jolla’s low blood pressure treatment clears key study
Feb 27 La Jolla Pharmaceutical Co said its lead experimental drug to treat low blood pressure met the main goal of a late-stage study on patients with distributive shock who have not adequately responded to existing treatments. Distributive shock is a state in which the heart is pumping well enough, but the blood is not distributed properly to the vital organs leading to severe hypotention.
New study confirms benefits of Medtronic’s Solitaire stent…
… four of the global randomized clinical trials that helped to transform stroke treatment are applicable in different health systems across the U.S. with the same positive results,” said Curtis Given, M.D., co-director, Neurointerventional Services, …
Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections
Pfizer Inc. said that it received two subpoenas from the U.S. Attorney’s office in Massachusetts related to charities that help Medicare patients afford co-payments for drugs, the latest company to disclose involvement in the probe. The New York-based drugmaker said in a securities filing Thursday that it received subpoenas on December 2015 and on July 2016 requesting documents related to the Patient Access Network Foundation and other organizations that provide financial assistance to Medicare patients.
Global Alzheimer’s Disease Diagnostic Market is expected to grow at a CAGR over 10% post 2022
Alzheimer’s Disease Diagnostic Market Analysis and Forecast by Type , Diagnostic Test , End Users – 2022 Major Key Players are Eli Lilly and Company , TauRx , Alector LLC , Accera, Inc. , Treventis Corporation , Neuro-Bio Ltd ” PUNE, MAHARASHTRA, INDIA, February 24, 2017 / EINPresswire.com / — Market Highlights Alzheimer’s is a type of dementia which causes failure of the functioning of the brain. This disease damages the areas which is responsible for the thinking, problem solving and behavior process.
Doctor-rating websites lack helpful information
… really looking for is a review from fellow patients to find a doctor who shares their values,” Lagu told Reuters Health. During September 2016, Lagu and colleagues searched for public websites that allow patients to review doctors in the U.S., …
New HIV infections fall in the US, but demographic and geographic disparities persist
Public domain image by the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention www.cdc.gov The number of annual new HIV infections in the US fell by 18% overall since 2008, offering evidence that prevention and treatment efforts are having an impact, according to data from the US Centers for Disease Control and Prevention released on Tuesday to coincide with presentations at the 2017 Conference on Retroviruses and Opportunistic Infections in Seattle. A closer look at the data, however, shows some notable differences across demographic groups and geographic regions.
BIDMC scientists survey the state of sleep science
… Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth …
ARMC rated among top 100 U.S. hospitals
Alamance Regional Medical Center has been rated among the nation’s best 100 hospitals by Healthgrades, a Denver company that compiles information on physicians, hospitals and health care providers. The distinction places ARMC in the top 2 percent of more than 4,500 hospitals nationwide for consistent, year-over-year superior clinical performance, according to Cone Health, which owns ARMC as well as MedCenter Mebane.
Research teams hone in on Zika vaccines, but challenges remain
… a microcephaly case in Brazil. The virus is associated with cellular membranes in the center. Credit: NIAID As public health officials warn that spring’s warmer temperatures may herald another increase of Zika virus infections in the Caribbean and …
Why GlaxoSmithKline’s 2017 Guidance Is Conservative
Assuming that Advair will face competition from a substitutable generic in the US by mid-2017, GSK guided for flat to a slight decline in Core EPS at constant exchange rates. The stock is trading at a discount to five years average historical P/E vs. peers and some potential source of earnings upside is expected in 2017.
Cory Booker Blocks Importation Of Cheaper Drugs; Will Trump Clap Back?
… drugs: Trump has supported allowing consumers to re-import drugs from abroad, and mentioned having the Medicare health program for the elderly negotiate prices directly with pharmaceutical manufacturers. Both ideas have long been opposed by the …
Penn State students raise $10 million-plus in dance marathon
Hundreds of hardy Penn State students raised more than $10 million for pediatric cancer patients in the annual 46-hour dance marathon known as Thon. The $10,045,478.44 total was announced Sunday afternoon at the conclusion of the Penn State Interfraternity Council/Panhellenic Dance Marathon, billed as the world’s largest student-run philanthropy.
Pfizer Near A Technical Breakout
Technically we continue to print higher lows and higher highs. Also the daily moving averages look set to cross over pretty soon.
Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.
However, when picking a stock, past performance isn’t nearly as important as what the future might hold. Which of these two drug stocks has an edge looking down the road? Here’s what the outlooks are for Gilead Sciences and Pfizer.
Health Highlights: Feb. 17, 2017
More deadly heat waves, catastrophic food shortages, and the rapid spread of some infectious diseases are all in the world’s future due to climate change, experts warned Thursday at the Climate & Health Meeting. The meeting, held at the Carter Center in Atlanta, was organized to replace a Centers for Disease Control and Prevention climate change conference that was canceled in January, ahead of President Donald Trump’s inauguration, CNN reported.
Myriad’s BRACAnalysis CDx Test Successfully Identified…
… targeting DNA damage response (DDR) mechanisms in cancer cells. Lynparza is currently approved by regulatory health authorities in the EU for use as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed …
Myriad’s Prolaris Test Significantly Improves the Risk…
Myriad Genetics, Inc. , a global leader in personalized medicine, today announced new data demonstrating the utility of the ProlarisA test to more accurately classify mortality risk and guide the management of newly diagnosed men with prostate cancer. The data are being presented at the 2017 Genitourinary Cancers Symposium meeting in Orlando, Fla.
Insulet Presents Strong Omnipod Horizona Hybrid Closed-Loop Study Results at ATTD in Paris
The study demonstrated that the Omnipod automated glucose control algorithm performed well, was safe during the day and night for adults with type 1 diabetes, and was very effective at night with minimal hypoglycemia and excellent fasting glucose. These data were presented today at the 10th International Conference on Advanced Technologies & Treatments for Diabetes in Paris, France.
From the Heart: Stories of survival that could save your life
… of heart problems. February is American Heart Month and Saint Francis is sponsoring its “One Heart. Be Smart. Health Fair.” Saturday, Feb. 25. The health fair will offer free screenings, educational displays, and mini-seminars to help people become …